Damora Therapeutics, Inc. (DMRA) Insider Ownership

Historic Insider Ownership Trends

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Advisors Llc Orbimed - 0 1,510,375 17 Aug, 2023
Jonathan Freve Chief Financial Officer 12,000 0 06 Dec, 2021
Jennifer Jarrett - 500,000 0 01 Apr, 2026
Funds Management Llc Fairmount - 0 8,713,000 12 Feb, 2026
Garrett Winslow General Counsel 1,854 0 06 Jan, 2026
Lori Firmani Chief Financial Officer 931 0 06 Jan, 2026
Hans T. Schambye Chief Executive Officer 4,682 0 06 Jan, 2026
Bertil Lindmark Chief Medical Officer 16,604 0 23 Mar, 2022
L. Becker Hewes Chief Medical Officer 264,629 0 07 Jan, 2026
Julianne Bruno - 137,032 0 12 Feb, 2026
Sherwin Sattarzadeh Chief Operating Officer 190,376 0 26 Jan, 2026

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
30 Mar, 2026 Jennifer Jarrett Common Stock A 500,000 $0.00 500,000 D A
30 Mar, 2026 Jennifer Jarrett Stock Option (right to buy) A 1,500,000 $0.00 1,500,000 D A
23 Mar, 2026 Funds Management Llc Fairmount Stock Option (right to buy) A 37,313 $0.00 37,313 I A
23 Mar, 2026 Cameron Turtle Stock Option (right to buy) A 37,313 $0.00 37,313 D A
23 Mar, 2026 Michael Landsittel Stock Option (right to buy) A 37,313 $0.00 37,313 D A
23 Mar, 2026 Garrett Winslow Stock Option (right to buy) A 250,000 $0.00 250,000 D A
23 Mar, 2026 Garrett Winslow Stock Option (right to buy) A 250,000 $0.00 250,000 D A
23 Mar, 2026 Christopher W. Cain Stock Option (right to buy) A 37,313 $0.00 37,313 D A
23 Mar, 2026 Julianne Bruno Stock Option (right to buy) A 37,313 $0.00 37,313 D A
23 Mar, 2026 Michael Landsittel Stock Option (right to buy) A 37,313 $0.00 37,313 D A
23 Mar, 2026 Cameron Turtle Stock Option (right to buy) A 37,313 $0.00 37,313 D A
09 Feb, 2026 Funds Management Llc Fairmount Common Stock A 5,809,000 $0.00 5,809,000 I M
09 Feb, 2026 Julianne Bruno Common Stock A 129,000 $0.00 137,032 D M
09 Feb, 2026 Julianne Bruno Series C Preferred Stock D 129 $0.00 0 D M
09 Feb, 2026 Funds Management Llc Fairmount Common Stock A 2,904,000 $0.00 2,904,000 I M
09 Feb, 2026 Funds Management Llc Fairmount Series C Preferred Stock D 5,809 $0.00 1,148 I M
09 Feb, 2026 Funds Management Llc Fairmount Series C Preferred Stock D 2,904 $0.00 574 I M
05 Jan, 2026 Sherwin Sattarzadeh Common Stock A 190,376 $0.00 190,376 D A
05 Jan, 2026 Sherwin Sattarzadeh Common Stock A 190,376 $0.00 190,376 D A
05 Jan, 2026 Sherwin Sattarzadeh Stock Option (right to buy) A 444,209 $0.00 444,209 D A